Examkin

Soru

Zorluk: KolayNeonatal Disorders

A term neonate born at 39 weeks gestation is diagnosed with alloimmune hemolytic disease secondary to ABO incompatibility. The infant's unconjugated total serum bilirubin levels are monitored closely. Management of neonatal hyperbilirubinemia follows a specific escalation protocol based on neurotoxicity risk factors and bilirubin levels to prevent kernicterus. Arrange the following therapeutic interventions in the correct standard sequence of clinical escalation, starting from the most basic baseline management to the most invasive rescue therapy.

  1. 1Optimize enteral feeding and ensure adequate hydration
  2. 2Initiate intensive phototherapy
  3. 3Administer intravenous immunoglobulin (IVIG)
  4. 4Perform a double-volume exchange transfusion

Cevap

The standard sequence of escalation is: Optimize enteral feeding and ensure adequate hydration, followed by Initiation of intensive phototherapy, then Administration of intravenous immunoglobulin (IVIG), and finally Performing a double-volume exchange transfusion.
The treatment of neonatal hyperbilirubinemia follows a stepwise escalation based on bilirubin neurotoxicity risk. Baseline management involves maximizing enteral feeding to ensure adequate stooling, which interrupts the enterohepatic circulation of bilirubin. If bilirubin rises to the phototherapy threshold on the risk-stratified nomogram, intensive phototherapy is initiated to convert unconjugated bilirubin into excretable, water-soluble isomers. In cases of isoimmune hemolytic disease (such as ABO or Rh incompatibility) where bilirubin continues to rise rapidly toward exchange transfusion levels despite intensive phototherapy, IVIG is administered to block red blood cell destruction. Finally, if the bilirubin level reaches critical thresholds or the infant demonstrates signs of acute bilirubin encephalopathy, double-volume exchange transfusion is emergently performed as a definitive rescue measure.

Adım Adım Çözüm

1
Identify the foundational requirement for all jaundiced neonates.
Optimize enteral feeding and ensure adequate hydration is the first step.
Enteral feeding promotes stooling, which is the primary route of bilirubin excretion, thereby minimizing enterohepatic recirculation.
2
Determine the first-line active medical intervention when bilirubin crosses the treatment threshold.
Initiate intensive phototherapy is the second step.
Phototherapy is a safe, non-invasive method that structurally isomerizes unconjugated bilirubin into water-soluble forms that can be excreted in urine and bile.
3
Select the next pharmacological step for isoimmune hemolytic disease refractory to initial therapy.
Administer intravenous immunoglobulin (IVIG) is the third step.
IVIG is specifically indicated in alloimmune hemolytic disease when bilirubin approaches exchange levels despite phototherapy; it reduces hemolysis by blocking Fc receptors.
4
Identify the ultimate rescue therapy for critically severe hyperbilirubinemia.
Perform a double-volume exchange transfusion is the final step.
This highly invasive procedure is reserved as a last resort to rapidly decrease total bilirubin and remove maternal antibodies when all other measures fail or if neurological symptoms appear.

Anahtar Kavram

Escalation protocol for neonatal alloimmune hyperbilirubinemia
Bu soruyu puanla

Konular

Neonatal Disorders

Bu konudan daha fazla soru